People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Abvc Biopharma, Inc. | — | Biotechnology | Seed | $4.5M | $3.9M | 2023 |
Tsang-Shann Jiang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tsang-Shann Jiang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Francis Chen | 1 | 3 |
| Tsung-Shann (T.S.) Jiang | 1 | 1 |
| Hsin-Hui Miao | 1 | 1 |
| Uttam Patil | 1 | 1 |
| Norimi Sakamoto | 1 | 1 |
| Che-Wei Hsu | 1 | 1 |
| Leeds Chow | 1 | 1 |
| Yoshinobu Odaira | 1 | 1 |
| Yu-Min (Francis) Chung | 1 | 1 |
| Yen-Hsin Chou | 1 | 1 |
| Chang-Jen Jiang | 1 | 1 |
| Shuling Jiang | 1 | 1 |
| Tsang Ming Jiang | 1 | 1 |
| Howard Doong | 1 | 1 |
| Eugene Jiang | 1 | 1 |
| Ming-Fong Wu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.